New Zealand markets open in 8 hours 35 minutes

IRADIMED CORPORATION (46K.SG)

Stuttgart - Stuttgart Delayed price. Currency in EUR
Add to watchlist
44.00-0.40 (-0.90%)
As of 08:01AM CEST. Market open.
Currency in EUR

Valuation measures4

Market cap (intra-day) 568.82M
Enterprise value 524.96M
Trailing P/E 33.39
Forward P/E 28.49
PEG ratio (5-yr expected) N/A
Price/sales (ttm)8.94
Price/book (mrq)7.75
Enterprise value/revenue 8.30
Enterprise value/EBITDA 25.90

Trading information

Stock price history

Beta (5Y monthly) 0.81
52-week change 323.33%
S&P500 52-week change 331.40%
52-week high 344.60
52-week low 334.60
50-day moving average 341.61
200-day moving average 340.16

Share statistics

Avg vol (3-month) 31
Avg vol (10-day) 3N/A
Shares outstanding 512.67M
Implied shares outstanding 612.82M
Float 87.1M
% held by insiders 137.01%
% held by institutions 155.93%
Shares short 4N/A
Short ratio 4N/A
Short % of float 4N/A
Short % of shares outstanding 4N/A
Shares short (prior month ) 4N/A

Dividends & splits

Forward annual dividend rate 40.54
Forward annual dividend yield 41.22%
Trailing annual dividend rate 30.30
Trailing annual dividend yield 30.68%
5-year average dividend yield 4N/A
Payout ratio 420.55%
Dividend date 3N/A
Ex-dividend date 420 Aug 2024
Last split factor 2N/A
Last split date 3N/A

Financial highlights

Currency in USD.

Fiscal year

Fiscal year ends 31 Dec 2023
Most-recent quarter (mrq)30 Jun 2024

Profitability

Profit margin 26.83%
Operating margin (ttm)31.39%

Management effectiveness

Return on assets (ttm)15.64%
Return on equity (ttm)25.08%

Income statement

Revenue (ttm)69.48M
Revenue per share (ttm)5.50
Quarterly revenue growth (yoy)11.20%
Gross profit (ttm)N/A
EBITDA 22.26M
Net income avi to common (ttm)18.64M
Diluted EPS (ttm)1.33
Quarterly earnings growth (yoy)17.30%

Balance sheet

Total cash (mrq)48.54M
Total cash per share (mrq)3.83
Total debt (mrq)371.85k
Total debt/equity (mrq)0.47%
Current ratio (mrq)9.86
Book value per share (mrq)6.29

Cash flow statement

Operating cash flow (ttm)15.83M
Levered free cash flow (ttm)8.87M